News
Takeda Pharmaceutical Company Limited (NYSE:TAK)’s ADCETRIS® (brentuximab vedotin) in combination with ECADD was authorized ...
As the lump in Makaila Chenier's neck grew, it became difficult for her to breathe. That's when she knew she needed to see a ...
Stage 4 lymphoma is a blood cancer that has spread outside of the lymph nodes to other parts of the body. Learn the symptoms, ...
Takeda (NYSE:TAK) (4502.T) said on Monday that the European Commission approved Pfizer (NYSE:PFE) and the company's ...
A Phase 3 study assessed the second-line use of sintilimab combined with ICE vs placebo combined with ICE in managing patients with classical Hodgkin Lymphoma.
Lucknow: When Prabhat Ranjan looked in the mirror at 110 kg, he barely recognised himself. Once a school-level cyclist, the demands of work had long t.
Beloved Australian actor, Magda Szubanski, has revealed she's been diagnosed with a "very rare, very aggressive, very serious ...
Lymphomas are cancers that start in white blood cells called lymphocytes. There are 2 main types of lymphoma: Hodgkin lymphoma (HL) Non-Hodgkin lymphoma (NHL) HL and NHL come from different types of ...
This type of lymphoma has been linked to hepatitis C infection. Treatment for the hepatitis C virus is discussed in detail in Treating B-cell Non-Hodgkin Lymphoma. This fast-growing lymphoma is named ...
The leading PD-1+ NSCLC Companies such as Arcus Biosciences, Akeso Biopharma, Biotheus, GlaxoSmithKline, AstraZeneca, Pfizer, Shandong Boan Biotechnology, Genor Biopharma and others. Promising PD-1+ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results